GSK3 inhibition improves skeletal muscle function and whole-body metabolism in male mouse models of Duchenne muscular dystrophy

Abstract Inhibiting glycogen synthase kinase 3 (GSK3) improves muscle function, metabolism, and bone health in many diseases and conditions; however, whether GSK3 should be targeted for Duchenne muscular dystrophy (DMD), a severe muscle wasting disorder with no cure, remains unknown. Here, we show t...

Full description

Saved in:
Bibliographic Details
Main Authors: Bianca M. Marcella, Briana L. Hockey, Jessica L. Braun, Kennedy C. Whitley, Mia S. Geromella, Ryan W. Baranowski, Colton J. F. Watson, Sebastian Silvera, Sophie I. Hamstra, Luc J. Wasilewicz, Robert W. E. Crozier, Amélie A. T. Marais, Kun Ho Kim, Gabsang Lee, Rene Vandenboom, Brian D. Roy, Adam J. MacNeil, Rebecca E. K. MacPherson, Val A. Fajardo
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-53886-y
Tags: Add Tag
No Tags, Be the first to tag this record!